Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Manning Paul B, Director. Director active across 6 companies, notably Taysha Gene Therapies, Inc.. Cumulatively, 30 disclosures have been recorded. Breakdown: 20 buys · 1 sell. Total volume traded: €53.9m. Activity tracked since 14 May 2021. The latest transaction was disclosed on 23 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Manning Paul B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20,000 shares@ US$12.541.1% of flowCommon StockSEC:0001209191-21-066702:0
Canonical exit: 21 Feb 2022 (T+90)
25 of 30 declarations
About Manning Paul B
Manning Paul B is Administrateur. He has 30 filings in total, covering the period from 2021-05-17 to 2026-02-26 in the sampled filings, with buy volume of EUR 50248409 and sell volume of EUR 3691438.